Page 3 - Graybug Vision News Today

The global retinal vein occlusion treatment market is likely to register a CAGR of 5.9% from 2023 to 2033. According to Future Market Insights, a valuation of US$ 2.3 billion is expected for the industry by the end of 2023. Retinal vein occlusion is among the most pervasive retinal vascular ailments in older individ...

Dublin, March 14, 2023 (GLOBE NEWSWIRE) -- The "Retinal Disorder Treatment Market Size, Share & Trends Analysis Report By Type (Macular Degeneration,...

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC are investigating the proposed merger of Graybug Vision, Inc. with CalciMedica Inc.... | February 14, 2023

The global retinal vein occlusion therapy market is predicted to be worth US$ 2.3 billion in 2023, with a compound yearly growth rate (CAGR) of 5.9% to reach US$ 4.7 billion by 2033. Retinal vein occlusion is one of the most common retinal vascular disorders in the elderly, affecting adults over the age of 65. Age i...

Tech companies, Seoul Robotics USA, SpyGlass Pharma Inc., Mammogen Inc., Diality Inc., Syntr Health Technologies Inc., have new launches

/PRNewswire/ -- DelveInsights Age-related Macular Degeneration Market Insights report includes a comprehensive understanding of current treatment practices,...

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Graybug Vision (NASDAQ:GRAY – Get Rating) had its price objective decreased by Piper Sandler from $4.00 to $2.00 in a research report sent to investors on Wednesday morning, The Fly reports. GRAY has been the subject of several other reports. Cantor Fitzgerald reduced their target price on Graybug Vision from $4.00 to $2.50 in a […]

Graybug Vision, Inc. (NASDAQ:GRAY – Get Rating) was the target of a significant increase in short interest in the month of April. As of April 30th, there was short interest totalling 62,900 shares, an increase of 60.5% from the April 15th total of 39,200 shares. Approximately 0.5% of the company’s stock are sold short. Based […]

Graybug Vision, Inc. (NASDAQ:GRAY – Get Rating) has received an average rating of “Hold” from the seven research firms that are currently covering the stock, Marketbeat Ratings reports. Five analysts have rated the stock with a hold recommendation and two have assigned a buy recommendation to the company. The average 1-year price objective among analysts […]